Ryan Specialty (NYSE:RYAN) Releases Earnings Results, Beats Expectations By $0.02 EPS

Ryan Specialty (NYSE:RYAN – Get Free Report) announced its earnings results on Thursday. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.49 by $0.02, FiscalAI reports. The business had revenue of $789.96 million during the quarter, compared to the consensus estimate of $792.99 million. Ryan Specialty had a net margin of 7.55% and a return on equity of 43.97%. During the same quarter in the previous year, the firm posted $0.47 EPS.

Here are the key takeaways from Ryan Specialty’s conference call:

  • Third-quarter results remained resilient: revenue increased 4.7% to $790 million, organic growth was 4%, adjusted EBITDAC rose 3.8% to $244 million, and adjusted EPS grew 8.5% to $0.51 despite a difficult comparison.
  • Market conditions are becoming more competitive, with continued property pricing declines, broader casualty competition, new capacity in delegated authority, and softness in builders risk. Management expects further property pricing deterioration in the fourth quarter and into 2027, while full-year adjusted EBITDAC margin is expected to decline modestly.
  • Management raised its 2026 outlook for organic revenue growth to the higher end of its mid-single-digit range and cited cost discipline, Empower efficiencies, strong producer retention, and the eventual accretion of its late-2025 hiring class as margin and growth tailwinds.
  • Ryan Specialty is expanding AI-related insurance offerings and internal automation, including a $625 million GPU facility and expanded transit coverage of up to $100 million per shipment. The company also repurchased $150 million of shares in the quarter and had $100 million remaining under its authorization.
  • Management sees potential for a more active M&A environment in 2027 and continued growth in reinsurance, delegated authority, data-center infrastructure, and other complex specialty risks, supported by strong client demand and the company’s specialty distribution platform.

Ryan Specialty Price Performance

Shares of NYSE:RYAN traded up $0.57 during trading on Thursday, reaching $43.19. 1,990,006 shares of the company traded hands, compared to its average volume of 1,929,863. The company’s 50 day moving average is $40.41 and its two-hundred day moving average is $39.20. The firm has a market capitalization of $11.05 billion, a PE ratio of 59.99, a PEG ratio of 0.87 and a beta of 0.61. The company has a quick ratio of 1.00, a current ratio of 1.00 and a debt-to-equity ratio of 3.51. Ryan Specialty has a 52 week low of $29.28 and a 52 week high of $58.94.

Analyst Upgrades and Downgrades

Several research firms have recently commented on RYAN. Citigroup upped their target price on Ryan Specialty from $50.00 to $53.50 and gave the company a “buy” rating in a research report on Monday, August 3rd. Keefe, Bruyette & Woods lifted their price target on Ryan Specialty from $48.00 to $54.00 and gave the stock an “outperform” rating in a report on Friday, July 31st. Barclays boosted their price target on Ryan Specialty from $46.00 to $48.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. UBS Group upped their price objective on Ryan Specialty from $50.00 to $55.00 and gave the company a “buy” rating in a report on Monday, August 3rd. Finally, Piper Sandler lowered their price objective on Ryan Specialty from $48.00 to $40.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 6th. Eight investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $52.21.

View Our Latest Research Report on RYAN

Key Stories Impacting Ryan Specialty

Here are the key news stories impacting Ryan Specialty this week:

  • Positive Sentiment: Third-quarter adjusted earnings per share were $0.51, exceeding the $0.49 analyst consensus. Revenue rose 4.7% year over year to approximately $790 million, while net income increased 40.6% to $88 million. Ryan Specialty Q3 Adjusted Earnings, Revenue Rise
  • Positive Sentiment: Ryan Specialty returned $173.7 million to shareholders during the quarter, including $150 million in stock repurchases and $23.7 million in dividends and distributions. The company also maintained its full-year outlook for mid-single-digit organic revenue growth. Ryan Specialty Q3 Revenue Rises 4.7% to $790 Million
  • Neutral Sentiment: Revenue was slightly below the approximately $793 million analyst estimate, making the quarter a mixed result despite the EPS beat. Ryan Specialty earnings results
  • Negative Sentiment: Organic revenue growth slowed to 4%, a deceleration that raised concerns about the company’s underlying expansion rate. Management also indicated that the full-year adjusted EBITDAC margin could decline modestly from the prior year. Ryan Specialty organic growth slows to 4% in Q3 earnings beat
  • Negative Sentiment: The balance sheet remains highly leveraged, with approximately $3.7 billion of outstanding debt and a debt-to-equity ratio of 3.51. That leverage may limit flexibility if growth or profitability weakens. Ryan Specialty posts mixed Q3 2026 results

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty Holdings, Inc is a specialty insurance services company that provides wholesale brokerage, managing general underwriting and delegated authority solutions. The company works with retail insurance brokers, agents, carriers and other market participants to place and manage complex, specialty risks that may require specialized underwriting expertise or customized coverage.

Its business includes specialty insurance and reinsurance brokerage, underwriting management and insurance program administration.

Read More

Earnings History for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.